Nature Aging-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2024-05-07 ms7000000703176276 来自广东省

投稿第9天，看了大家经验感觉机会渺茫。。。

99 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2022-01-25 ms2893900752900076

这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。

344 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2024-05-10 ms7000000703176276 来自广东省

偏重的研究方向：衰老;抗衰老
经验分享：投稿12天状态未变化

117 0

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2024-05-10 ms7000000703176276 来自广东省

投稿12天了，还在consideration，机会渺茫啊😭

115 0

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2023-06-29 ms6000002144421454 来自上海

偏重的研究方向：衰老;老年性痴呆
经验分享：请问这个期刊从投出到返修需要多久

190 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2023-07-26 ms1000000582868380 来自浙江省

投稿命中率:5.0
偏重的研究方向：衰老
经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell

173 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2024-04-14 ms2000000842899520 来自广东省

123

125 0

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2023-12-23 侠胆医心来自威斯康星

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：衰老;老年病学;抗衰老
经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。

149 0

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2023-04-19 侠胆医心来自香港

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：衰老;老年性痴呆;退行性病变
经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈

201 0

[GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天，看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题，随便找两篇和你研究不相关文献，说你创新性不足，拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向：衰老;抗衰老 经验分享：投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了，还在consideration，机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向：衰老;老年性痴呆 经验分享：请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0 偏重的研究方向：衰老 经验分享：在影响因子普遍回落的2022 nature aging首个IF就达到16.6，投稿难度已经是nature大子刊阶梯，要求非常高，后面IF必然二三十分衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：衰老;老年病学;抗衰老 经验分享：期刊在2023年公布的JCR（期刊印证报告）中作为ESCI期刊被收录，获得了16.6的影响因子。在此次12月WOS更新后，该期刊被SCI期刊目录收录，晋级成为SCI期刊（不再被ESCI数据库收录）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：衰老;老年性痴呆;退行性病变 经验分享：虽然是新刊，实际上不少文章都是从Nature主刊拒稿转投过来的，整体质量还是很高。想发表确实得拼创新，数据。尤其这几年衰老领域发展太快，竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很专业，非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]

2023-03-05 15944a2fc4m 来自江苏省

审稿速度:6.0 | 投稿命中率:5.0
经验分享：很专业，非常难

241 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务